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Abstract
Che-1 is a RNA polymerase II binding protein involved in the transcriptional regulation of E2F
target genes and in cell proliferation. Recently, it has been shown that Che-1 accumulates in cells
responding to genotoxic agents such as Doxorubicin and ionizing radiation. The DNA damage-
activated checkpoint kinases ATM and Chk2 interact with and phosphorylate Che-1, enhancing its
accumulation and stability, and promoting Che-1-mediated transcription of p53-responsive genes
and of p53 itself, as evidenced by microarray analysis. This transcriptional response is suppressed
by expression of a Che-1 mutant lacking ATM and Chk2 phosphorylation amino acid residues, or
by depletion of Che-1 by RNA silencing. In addition, chromatin immunoprecipitation analysis has
shown that Che-1 is released from E2F target genes and recruited to the p21 and p53 promoters
after DNA damage. Che-1 contributes to the maintenance of the G2/M checkpoint in response to
genotoxic stress. These findings identify a new mechanism by which the checkpoint kinases
regulate, via the novel effector Che-1, the p53 pathway. Lastly, increasing evidence suggests that
Che-1 may be involved in apoptotic signaling in neural tissues. In cortical neurons, Che-1 exhibits
anti-apoptotic activity, protecting cells from neuronal damage induced by amyloid β-peptide. In
cerebellar granule neurons, Che-1 interacts with Tau in the cytoplasmic compartment and this
interaction is modulated during neuronal apoptosis. Finally, Che-1 directly interacts with the
neuronal cell-death inducer "NRAGE" which downregulates endogenous Che-1 by targeting it for
proteasome-dependent degradation. These findings identify Che-1 as a novel cytoprotective factor
against apoptotic insults and suggest that Che-1 may represent a potential target for therapeutic
application.
Background
Che-1, also called AATF or Ded, is a phosphoprotein con-
taining 558 amino acids and has been identified as a RNA
polymerase II binding protein in a two-hybrid screen [1].
Human Che-1 was also cloned by differential display of
genes downregulated by TGFβ [2]. The human Che-1 gene
is located at chromosome 17q11.2-q12, and Che-1 is
highly conserved among eukaryotic species [2]. Che-1
expression is essential during the early steps of embryo-
genesis. Indeed, in the absence of a fully functional Traube
gene (the murine ortholog of Che-1), embryos halt in
development at the compacted morula stage and die 2
days later [3].
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One essential role of Che-1 is to promote cellular tran-
scription as an adaptor or mediator that links specific
transcription factors to the general transcription appara-
tus. Che-1 per se does not appear to possess DNA binding
activity, but Page et al. [4] showed that Che-1 exhibits
transactivation activity in a Gal4-linked reporter assay in
yeast, although in our hands only the acidic domain at the
N terminus of the molecule possesses this transactivation
activity. Che-1 binds nuclear hormone receptors directly
in vitro and enhances transactivation by several steroid
hormone receptors, including androgen, estrogen, and
glucocorticoid receptors in a hormone-dependent man-
ner [5]. In addition, Che-1 interacts with the tumor sup-
pressor TSG101, and together they function as
cooperative coactivators in androgen receptor-mediated
transcription [6]. Che-1 was previously shown to interact
with Rb and to affect its growth suppression activity by
interfering with the Rb-mediated recruitment of histone
deacetylase I to the promoters of E2F1-responsive genes
[1,7]. However, Che-1 was also downregulated in several
colon carcinomas and involved in growth arrest through
induction of p21Waf1 [8].
Che-1 is involved in DNA damage responses
Cell cycle checkpoints are regulatory pathways that govern
the order and timing of cell cycle transitions to ensure
completion of one cellular event prior to commencement
of another. The key regulators of the checkpoint pathways
in the mammalian DNA damage response are ATM and
ATR protein kinases [9]. Indeed, these proteins, once acti-
vated, phosphorylate directly or indirectly, via the check-
point kinases Chk1 and Chk2, several important effectors
such as p53, BRCA1, or NBS1 which are involved in cell
cycle arrest, DNA repair, and apoptosis [10,11]. In partic-
ular, the p53 protein plays a critical role in the cellular
response to DNA damage and other stresses by inhibiting
proliferation or inducing apoptosis [12].
In a recent paper, the involvement of Che-1 in the cellular
response to DNA damage was investigated [13]. In this
study, Che-1 protein half-life was found to be regulated by
the proteasome pathway and stabilized in response to
physical and chemical genotoxic agents, an effect medi-
ated by the kinases ATM and Chk2 which bind and phos-
phorylate Che-1 at four serine residues (Ser187 by ATM,
and Ser141, Ser 474, and Ser508 by Chk2). Notably, sub-
stitution of these residues abolished Che-1 stabilization in
response to DNA damage.
Since Che-1 is a RNA polymerase II binding protein, high-
density Affimetrix microarrays were used to identify Che-
1 target genes that might be relevant for the cellular
response to genotoxic stress. Among the induced genes,
the p53 oncosuppressor and several of its targets, e.g. cyc-
lin G, p21, MDM2, and P53DINP1, were identified [13].
Consistent with these results, Che-1 depletion signifi-
cantly decreased transcription of the p53 gene and other
target genes both in basal conditions and upon DNA dam-
age, supporting a role for Che-1 in their transcriptional
regulation.
Chromatin immunoprecipitation experiments revealed
that in response to DNA damage, Che-1 phosphorylation
displaces it from E2F target genes and increases its occu-
pancy at the p21 and TP53 promoters. From these findings
it is possible to propose a model in which, in response to
genotoxic stress, a molecular switch moves Che-1 from a
cell cycle progression pathway to growth arrest of the cell.
Bruno et al. [13] have shown that Che-1 interacts with the
NF-kB subunit p65 in response to DNA damage, and that
this interaction is mediated by Che-1 phosphorylation.
Thus, post-translational modifications not only modulate
Che-1 stability, but they may also mediate its interactions
with transcription factors or co-factors and in this way reg-
ulate its presence on specific promoters. Che-1 was also
found to be stabilized by phosphorylation during the G1/
S transition, although the responsible kinase/s was not
identified [7]. Therefore, several kinases may regulate
Che-1 levels and interactions by different pathways
depending upon specific cellular signals.
At the phenotypic level, Che-1 was found to be involved
in the maintenance of the G2/M checkpoint in response
to genotoxic stress, increasing the expression of p21Waf1
and repression of CDC25C by p53 [13], whereas an
involvement of Che-1 in the G1 checkpoint remains to be
established. In addition, Che-1 inhibition strongly
enhanced the cytotoxicity of anticancer drugs, thus sug-
gesting Che-1 as a possible therapeutic target to increase
the efficacy of DNA damaging drugs.
Based on these observations, it is reasonable to speculate
that Che-1 may be a component of the anticancer barrier
that protects cells from DNA damage or oncogenic stress
[14,15] by inducing cellular senescence [16,17]. Consist-
ent with this hypothesis, Che-1 contains a conserved
motif (EExxxDDL) required by several important proteins
involved in the DNA damage response, such as NSB1,
Ku80 and ATRIP, for their interaction with ATM, DNA-
PKcs, and ATR, respectively [18]. This motif is critical for
kinase-mediated signaling events that trigger cell cycle
checkpoints and DNA repair.
Recently, p53 isoforms were described [19], revealing the
existence of an alternative p53 promoter and that expres-
sion of these isoforms can regulate p53 transcriptional
activity. Thus, it is possible that Che-1 could also affect the
activity of the p53 alternative promoter, regulating in this
way the effect of p53 on growth arrest and apoptosis.Cell Division 2007, 2:21 http://www.celldiv.com/content/2/1/21
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Model to explain Che-1 modulation Figure 1
Model to explain Che-1 modulation. Non apoptotic genotoxic stresses induce Che-1 stabilization through its phosphor-
ylation by ATM and Chk2. Stabilization of Che-1 produces an increase of p53 and p21 expression and contributes to arrest cell 
growth in response to DNA damage. Apoptotic DNA damage induces Che-1 Thr144 phosphorylation and Che-1/Pin1 interac-
tion. Pin1 catalyzes Che-1 conformational changes, increasing Che-1/HDM2 interaction and in such way Che-1 degradation. In 
cortical neurons, NRAGE inhibits nuclear localization of Che-1, by sequestering it within the cytoplasmic compartment, and 
down-regulates endogenous Che-1 by targeting it for proteasome-dependent degradation.Cell Division 2007, 2:21 http://www.celldiv.com/content/2/1/21
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More recently, we demonstrated that, in response to apop-
totic stimuli, HDM2/MDM2 protein negatively regulates
Che-1 by promoting its ubiquitin-mediated degradation
[20]. Che-1 was found to be a direct target of HDM2/
MDM2 and that this interaction is increased following
induction of apoptosis. The HDM2/MDM2-Che-1 inter-
action resulted in regulation by Pin1, which modifies the
structure of Che-1, increasing its capacity to interact with
HDM2/MDM2. Indeed, Pin1 bound Che-1 only upon
Dox-mediated apoptosis, and siRNA-mediated Pin1
depletion strongly decreased HDM2/MDM2-Che-1 inter-
actions, resulting in Che-1 stabilization [20].
In agreement with previous findings [4,7], Che-1 is con-
firmed to be an anti-apoptotic factor and that its degrada-
tion is required for executing the apoptotic program.
Therefore, it possible to speculate that Pin1 is required for
the apoptotic response to DNA damage not only by stabi-
lizing p53 and p73 [21-23] but also by increasing Che-1
degradation.
Che-1: additional roles in neuronal cell apoptosis 
and homeostasis
Cell death programs are essential for embryonic develop-
ment and maintenance of tissue homeostasis in multicel-
lular organisms. Circumstantial evidence suggests that
Che-1 is likely involved in apoptotic signaling in neural
tissues in both normal and pathologic conditions. In par-
ticular, neuronal degeneration in Alzheimer's disease may
be caused by extracellular accumulation of aggregated,
neurotoxic amyloid β peptide 1–42. Che-1, in cortical
neurons, exhibits anti-apoptotic activity, protecting cells
from neuronal damage induced by amyloid β-peptide.
Che-1 exerts this neuronal protection by interacting
directly with the pro-apoptotic transcription factor Par-4
and inhibiting its ability to stimulate aberrant production
of amyloid β peptide 1–42 [27,28]. In cerebellar granule
neurons, Che-1 directly interacts with Tau, a microtubule-
associated protein involved in the assembly and stabiliza-
tion of the neuronal microtubule network that plays a cru-
cial role in modulating neuronal morphogenesis, axonal
shape, and transport. Tau undergoes a complex pattern of
physiological and pathological post-translational
changes, and it is the major component of the intraneuro-
nal fibrillar lesions that characterize Alzheimer's disease
and the neurodegenerative tauopathies [29]. Che-1/Tau
association takes place in the cytoplasmic compartment of
neuronal cells and it is finely modulated during the onset
of neuronal apoptosis [30] (Fig 1).
Finally, Che-1 directly interacts with the neurotrophilin
receptor-interacting MAGE homolog "NRAGE" [31].
NRAGE has been recently identified as a novel cell-death
inducer involved in molecular events driving cells
through apoptotic networks during neuronal develop-
ment [32]. NRAGE inhibits Che-1 nuclear localization by
sequestering it within the cytoplasmic compartment. Fur-
thermore, while NRAGE overexpression downregulates
endogenous Che-1 by targeting it for proteasome-depend-
ent degradation, Che-1 acts as functional antagonist of
NRAGE, since its overexpression completely reverts
NRAGE-induced cell-death.
Concluding remarks
Increasing evidence points at Che-1 as a critical actor in
multiple molecular pathways. The significance of its role
is growing because of its activities in transcriptional regu-
lation, cell cycle control, DNA damage responses, and in
the execution of cell death programs. Potential new roles
for Che-1 in neuronal development, tissue homeostasis,
and pathology underscore an even more complex molec-
ular network. Finally, the emerging broad cytoprotective
role of Che-1 identifies it as potential target for therapeu-
tics.
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